CUAMC
ONCR

China Universal Asset Management Company’s Oncorus, Inc. ONCR Stock Holding History

China Universal Asset Management Company’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-243
Closed – – 497
2022
Q3 		$0 Buy
+243
New +$312 ﹤0.01% 472

Other funds holding ONCR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

China Universal Asset Management Company's ONCR Position: Q4 2022 in Review

China Universal Asset Management Company sold out of Oncorus, Inc. (ONCR) in Q4 2022, closing a stake of 243 shares.

China Universal Asset Management Company first reported a position in ONCR in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 33 funds tracked by Wall St. Rank hold ONCR as of Q4 2022.

  • China Universal Asset Management Company reported no remaining Oncorus, Inc. position as of Q4 2022 after selling out during the quarter.
  • China Universal Asset Management Company sold 243 Oncorus, Inc. shares in Q4 2022.
  • China Universal Asset Management Company first reported a position in Oncorus, Inc. in Q3 2022 and held it in 1 quarter.
  • China Universal Asset Management Company's Oncorus, Inc. position peaked at $0 in Q3 2022.
  • 33 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q4 2022.

Based on China Universal Asset Management Company's 13F filing for Q4 2022, filed 31 Jan 2023.